Caxton Associates (New York)’s Avnet AVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,201
Closed -$826K 501
2024
Q3
$826K Sell
15,201
-10,581
-41% -$557K 0.03% 276
2024
Q2
$1.33M Sell
25,782
-48,630
-65% -$2.49M 0.05% 209
2024
Q1
$3.69M Buy
74,412
+19,656
+36% +$921K 0.21% 57
2023
Q4
$2.76M Buy
54,756
+28,243
+107% +$1.34M 0.14% 85
2023
Q3
$1.28M Buy
+26,513
New +$1.28M 0.18% 110
2023
Q2
Sell
-33,716
Closed -$1.52M 498
2023
Q1
$1.52M Buy
33,716
+15,197
+82% +$677K 0.23% 81
2022
Q4
$770K Buy
18,519
+5,979
+48% +$249K 0.05% 163
2022
Q3
$453K Buy
+12,540
New +$540K 0.06% 260
2022
Q2
Sell
-6,341
Closed -$257K 565
2022
Q1
$257K Sell
6,341
-15,955
-72% -$658K 0.02% 391
2021
Q4
$919K Buy
+22,296
New +$861K 0.09% 125
2020
Q3
Sell
-9,746
Closed -$272K 314
2020
Q2
$272K Buy
+9,746
New +$271K 0.02% 291
2020
Q1
Sell
-12,515
Closed -$531K 414
2019
Q4
$531K Buy
12,515
+4,327
+53% +$178K 0.07% 165
2019
Q3
$364K Buy
+8,188
New +$354K 0.07% 208
2017
Q2
Sell
-12,300
Closed -$563K 467
2017
Q1
$563K Buy
+12,300
New +$569K ﹤0.01% 217

Other funds holding AVT

Caxton Associates (New York)'s AVT Position: Q4 2024 in Review

Caxton Associates (New York) sold out of Avnet (AVT) in Q4 2024, closing a stake of 15,201 shares — an estimated $826K sold.

Caxton Associates (New York) first reported a position in AVT in Q1 2017 and held it in 14 quarters. The position peaked at $3.69M in Q1 2024. 370 funds tracked by Wall St. Rank hold AVT as of Q4 2024.

  • Caxton Associates (New York) reported no remaining Avnet position as of Q4 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 15,201 Avnet shares in Q4 2024, an estimated $826K.
  • Caxton Associates (New York) first reported a position in Avnet in Q1 2017 and held it in 14 quarters.
  • Caxton Associates (New York)'s Avnet position peaked at $3.69M in Q1 2024.
  • 370 funds tracked by Wall St. Rank held Avnet as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.